Search Results - "Huso, David. L."

Refine Results
  1. 1
  2. 2

    Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma by Gerber, Elizabeth E., Gallo, Elena M., Fontana, Stefani C., Davis, Elaine C., Wigley, Fredrick M., Huso, David L., Dietz, Harry C.

    Published in Nature (London) (07-11-2013)
    “…Failure of integrin-mediated cell-matrix attachment is sufficient to initiate dermal fibrosis and autoimmunity in mouse models of scleroderma;…”
    Get full text
    Journal Article
  3. 3
  4. 4

    HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells by Shah, Sandeep N, Cope, Leslie, Poh, Weijie, Belton, Amy, Roy, Sujayita, Talbot, Jr, C Conover, Sukumar, Saraswati, Huso, David L, Resar, Linda M S

    Published in PloS one (02-05-2013)
    “…Emerging evidence suggests that tumor cells metastasize by co-opting stem cell transcriptional networks, although the molecular underpinnings of this process…”
    Get full text
    Journal Article
  5. 5

    A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome by Benjamin, Joel S., Pilarowski, Genay O., Carosso, Giovanni A., Zhang, Li, Huso, David. L., Goff, Loyal A., Vernon, Hilary J., Hansen, Kasper D., Bjornsson, Hans T.

    “…Kabuki syndrome is a Mendelian intellectual disability syndrome caused by mutations in either of two genes (KMT2D and KDM6A) involved in chromatin…”
    Get full text
    Journal Article
  6. 6

    HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells by Belton, Amy, Gabrovsky, Alexander, Bae, Young Kyung, Reeves, Ray, Iacobuzio-Donahue, Christine, Huso, David L, Resar, Linda M S

    Published in PloS one (20-01-2012)
    “…Although metastatic colon cancer is a leading cause of cancer death worldwide, the molecular mechanisms that enable colon cancer cells to metastasize remain…”
    Get full text
    Journal Article
  7. 7

    Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease by Cebotaru, Liudmila, Liu, Qiangni, Yanda, Murali K, Boinot, Clement, Outeda, Patricia, Huso, David L, Watnick, Terry, Guggino, William B, Cebotaru, Valeriu

    Published in Kidney international (01-07-2016)
    “…Abnormal proliferation of cyst-lining epithelium and increased intracystic fluid secretion via the cystic fibrosis transmembrane conductance regulator (CFTR)…”
    Get more information
    Journal Article
  8. 8
  9. 9

    HMGA1 amplifies Wnt signalling and expands the intestinal stem cell compartment and Paneth cell niche by Xian, Lingling, Georgess, Dan, Huso, Tait, Cope, Leslie, Belton, Amy, Chang, Yu-Ting, Kuang, Wenyong, Gu, Qihua, Zhang, Xiaoyan, Senger, Stefania, Fasano, Alessio, Huso, David L., Ewald, Andrew J., Resar, Linda M. S.

    Published in Nature communications (28-04-2017)
    “…High-mobility group A1 (Hmga1) chromatin remodelling proteins are enriched in intestinal stem cells (ISCs), although their function in this setting was…”
    Get full text
    Journal Article
  10. 10

    Polycystin Signaling Is Required for Directed Endothelial Cell Migration and Lymphatic Development by Outeda, Patricia, Huso, David L., Fisher, Steven A., Halushka, Marc K., Kim, Hyunho, Qian, Feng, Germino, Gregory G., Watnick, Terry

    Published in Cell reports (Cambridge) (01-05-2014)
    “…Autosomal dominant polycystic kidney disease is a common form of inherited kidney disease that is caused by mutations in two genes, PKD1 (polycystin-1) and…”
    Get full text
    Journal Article
  11. 11
  12. 12

    HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networks by Shah, Sandeep N, Kerr, Candace, Cope, Leslie, Zambidis, Elias, Liu, Cyndi, Hillion, Joelle, Belton, Amy, Huso, David L, Resar, Linda M S

    Published in PloS one (15-11-2012)
    “…Although recent studies have identified genes expressed in human embryonic stem cells (hESCs) that induce pluripotency, the molecular underpinnings of normal…”
    Get full text
    Journal Article
  13. 13

    Pericytes promote selective vessel regression to regulate vascular patterning by Simonavicius, Nicole, Ashenden, Matthew, van Weverwijk, Antoinette, Lax, Siân, Huso, David L., Buckley, Christopher D., Huijbers, Ivo J., Yarwood, Helen, Isacke, Clare M.

    Published in Blood (16-08-2012)
    “…Blood vessel networks form in a 2-step process of sprouting angiogenesis followed by selective branch regression and stabilization of remaining vessels…”
    Get full text
    Journal Article
  14. 14

    nanoparticle formulation that selectively transfects metastatic tumors in mice by Yang, Jian, Hendricks, William, Liu, Guosheng, McCaffery, J. Michael, Kinzler, Kenneth W., Huso, David L., Vogelstein, Bert, Zhou, Shibin

    “…Nanoparticle gene therapy holds great promise for the treatment of malignant disease in light of the large number of potent, tumor-specific therapeutic…”
    Get full text
    Journal Article
  15. 15

    Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulation by Ericson, Kajsa, Gan, Christine, Cheong, Ian, Rago, Carlo, Samuels, Yardena, Velculescu, Victor E, Kinzler, Kenneth W, Huso, David L, Vogelstein, Bert, Papadopoulos, Nickolas

    “…Phosphotidylinositol-3-kinase (PI3K) signaling is altered in the majority of human cancers. To gain insight into the roles of members of this pathway in growth…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Increased colonic inflammatory injury and formation of aberrant crypt foci in Nrf2‐deficient mice upon dextran sulfate treatment by Osburn, William O., Karim, Baktiar, Dolan, Patrick M., Liu, Guosheng, Yamamoto, Masayuki, Huso, David L., Kensler, Thomas W.

    Published in International journal of cancer (01-11-2007)
    “…Chronic inflammation has been associated with increased risk of developing cancer. The transcription factor NF‐E2‐related factor 2 (Nrf2) controls the…”
    Get full text
    Journal Article
  18. 18

    Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemia by Lim, Yiting, Gondek, Lukasz, Li, Li, Wang, Qiuju, Ma, Hayley, Ma, Haley, Chang, Emily, Huso, David L, Foerster, Sarah, Marchionni, Luigi, McGovern, Karen, Watkins, David Neil, Peacock, Craig D, Levis, Mark, Smith, Bruce Douglas, Merchant, Akil A, Small, Donald, Matsui, William

    Published in Science translational medicine (10-06-2015)
    “…FMS-like tyrosine kinase 3 (FLT3) internal tandem duplication (ITD) mutations resulting in constitutive kinase activity are common in acute myeloid leukemia…”
    Get more information
    Journal Article
  19. 19

    FLT3/D835Y mutation knock-in mice display less aggressive disease compared with FLT3/internal tandem duplication (ITD) mice by Bailey, Emily, Li Lia, Duffield, Amy S., Ma, Hayley S., Huso, David L., Small, Don

    “…FMS-like tyrosine kinase 3 (FLT3) is mutated in approximately one third of acute myeloid leukemia cases. The most common FLT3 mutations in acute myeloid…”
    Get full text
    Journal Article
  20. 20

    HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis by Schuldenfrei, Andrew, Belton, Amy, Kowalski, Jeanne, Talbot, Jr, C Conover, Di Cello, Francescopaolo, Poh, Weijie, Tsai, Hua-Ling, Shah, Sandeep N, Huso, Tait H, Huso, David L, Resar, Linda M S

    Published in BMC genomics (04-11-2011)
    “…Although the high mobility group A1 (HMGA1) gene is widely overexpressed in diverse cancers and portends a poor prognosis in some tumors, the molecular…”
    Get full text
    Journal Article